Ezetimibe and Electrocardiogram qt prolonged - a phase IV clinical study of FDA data

Summary:

Electrocardiogram qt prolonged is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Paracetamol, and have Depression.

The phase IV clinical study analyzes which people have Electrocardiogram qt prolonged when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Electrocardiogram qt prolonged?

Electrocardiogram qt prolonged is found to be associated with 1,394 drugs and 1,518 conditions by eHealthMe. Check the latest studies of Electrocardiogram qt prolonged.

On Jul, 17, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 30 people (0.1%) have Electrocardiogram qt prolonged.

Could Ezetimibe cause Electrocardiogram qt prolonged?

Among these 30 people:

How long have people been on Ezetimibe when they have Electrocardiogram qt prolonged? *

What is the gender of people who have Electrocardiogram qt prolonged when taking Ezetimibe? *

female: 37.04 %
male: 62.96 %

What is the age of people who have Electrocardiogram qt prolonged when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

What are other side effects people have besides Electrocardiogram qt prolonged? *

Oedema Peripheral (superficial swelling): 4 people, 13.33%
Fatigue (feeling of tiredness): 4 people, 13.33%
Face Oedema (swelling of face): 3 people, 10.00%
Gait Disturbance: 2 people, 6.67%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 6.67%
Ventricular Fibrillation (abnormally irregular heart rhythm): 2 people, 6.67%
Feeling Hot: 1 person, 3.33%
Dry Skin: 1 person, 3.33%
Dyspnea (difficult or laboured breathing): 1 person, 3.33%
Dysstasia (difficulty in standing): 1 person, 3.33%

What are the existing conditions these people have? *

Depression: 15 people, 50.00%
Fever: 7 people, 23.33%
Nicotine Dependence: 7 people, 23.33%
Insomnia (sleeplessness): 7 people, 23.33%
Pain: 2 people, 6.67%
Nausea (feeling of having an urge to vomit): 2 people, 6.67%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 6.67%
High Blood Pressure: 2 people, 6.67%
Dementia (madness): 2 people, 6.67%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Electrocardiogram qt prolonged?

- Check whether Electrocardiogram qt prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram qt prolonged:

Electrocardiogram qt prolonged (1,394 drugs)

Browse all the conditions that are associated with Electrocardiogram qt prolonged:

Electrocardiogram qt prolonged (1,518 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.